Answers are grounded in this paper and cite their sources.
It is now well established that antibodies have numerous potential benefits when developed as therapeutics. Here, we evaluate the technical challenges of raising antibodies to membrane-spanning proteins together with enabling technologies that may facilitate the discovery of antibody therapeutics to ion channels. Additionally, we discuss the potential targeting opportunities in the anti-ion channel antibody landscape, along with a number of case studies where functional antibodies that target ion channels have been reported. Antibodies currently in development and progressing towards the clinic are highlighted.
No takes yet. Share an insight, caveat, or question.
Hutchings et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: